SCHEMBL21702915

SCHEMBL21702915

Nc1cccn(Cc2nc3ccccc3[nH]2)c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.49
▸ HPGD P15428 2/20 0.47
▸ DDAH1 O94760 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ PON1 P27169 1/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ PDE10A Q9Y233 2/20 0.46
▸ PLAUR Q03405 1/20 0.45
▸ DRD4 P21917 3/20 0.45
▸ GAA P10253 2/20 0.44
▸ CHRM1 P11229 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ BCHE P06276 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21685451 0.83 DRD4 (0.40) HTTDRD4ALDH1A1MAPTSMN1; SMN2
SCHEMBL25939356 0.80 MAP4K1 (0.49) HTTHPGDDDAH1POLBPON1
SCHEMBL21703026 0.75 MAP4K1 (0.50) KDM4EALDH1A1MAPTHSD17B10
SCHEMBL23453061 0.74 MAP4K1 (0.39) POLBGAAMAPT
SCHEMBL21703024 0.74 MAP4K1 (0.37) KDM4EMAPTSMN1; SMN2
SCHEMBL21703236 0.74 ELANE (0.33) GAAMAPTNPSR1
SCHEMBL16812412 0.74 KDM4E (0.50) HPGDPOLBNPC1RAB9APLAUR
SCHEMBL23452764 0.74 MAP4K1 (0.42) HPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL23453060 0.74 MAP4K1 (0.38) HTTHPGDPOLBGAAKDM4E
SCHEMBL21703008 0.74 MAP4K1 (0.40) POLBGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 — — EP disclosed
WO-2020033784-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS SITARI PHARMA, INC. (US) 2020-02-13 — — WO disclosed
Send feedback